Skip to main content

USP 797 Guidelines: How the Right Software Can Help Address Safety Regulations

Neha Kharod, MD, Allergy, Asthma, and Immunology Specialist, Prime Care of Georgia | Luke Barratt, Senior Product Manager ModMed

PRESENTERS

Neha Kharod, MD, Allergy, Asthma, and Immunology Specialist, Prime Care of Georgia, Savannah

Luke Barratt, Director, Product Management, ModMed

This webinar was recorded on March 25, 2025.

USP 797, an updated national minimum standard for preparing compounded sterile drugs, went into effect on November 1, 2023. Learn about the purpose of this regulation, the specific requirements it set forth, and how using the right software can help your practice address these regulations.

You’ll hear from Neha Kharod, MD, a board-certified physician who cares for children and adults with asthma, allergic diseases and immunologic disorders, and ModMed® Director of Product Management Luke Barratt, who has designed and built automation platforms for allergen immunotherapy compounding.

YOU WILL LEARN

  • Common challenges that pose a risk to practices and patients
  • Why USP 797 is a critical safety-related standard
  • Components of the regulation that most directly impact practices like yours
  • How the right software can help address safety regulations